Monitoring Outpatient Blood VolumE in Heart Failure

CompletedOBSERVATIONAL
Enrollment

15

Participants

Timeline

Start Date

September 16, 2021

Primary Completion Date

July 15, 2022

Study Completion Date

July 30, 2022

Conditions
Heart Failure
Interventions
DEVICE

BVA-100

"The BVA-100 is a software package designed to calculate human blood volume using the method of tracer dilution. It uses tagged serum albumin (a commonly used tag is 131I, resulting in 131I -HSA). Data inputs to the software come from the measured characteristics of subject blood samples (hematocrit and tracer concentration) and tracer calibration standards. The package also calculates the subject expected (or ideal) blood volume from physical parameters. Hyper- or hypovolemia, associated red blood cell volumes, and transudation rate are reported, with statistics showing the quality of the results. The subject blood samples and calibration standards are measured in a gamma counter, whose output is automatically, or manually, input to this calculation program."

Trial Locations (1)

17821

Geisinger, Danville

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Geisinger Clinic

OTHER

lead

Daxor Corporation

INDUSTRY

NCT04660396 - Monitoring Outpatient Blood VolumE in Heart Failure | Biotech Hunter | Biotech Hunter